cancer research

Despite having yet to save the life of a mouse, an Israeli company is making grandiose pronouncements. However, if you look beyond the hype the medical approach is actually pretty interesting.
John LaMattina, the former head of R&D at Pfizer, tackles a timely and important topic in his Forbes piece today: What is the best way to do oncology research? And, can it save money as well as lives?
Modern clinical research has turned to harnessing a patient s own immune system to block the proliferation of cancer cells. The
By far, the major thrust of pharmaceutical research at this time is aimed at cancer. In 2102, a record eleven oncology drugs were approved by the FDA. Unfortunately, most advances have been incremental, and cures for most previously incurable cancers remain elusive.
Clinton Leaf, author of The Truth in Small Doses: Why We re Losing the War on Cancer